MabCure MBCI Stock
MabCure Price Chart
MabCure MBCI Financial and Trading Overview
| MabCure stock price | 0.0001 USD |
| Previous Close | 0.0004 USD |
| Open | 0.0004 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0004 - 0.0004 USD |
| 52 Week Range | 0.0002 - 0.0061 USD |
| Volume | 460 USD |
| Avg. Volume | 3.04K USD |
| Market Cap | 643.64K USD |
| Beta (5Y Monthly) | 0.02183 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MBCI Valuation Measures
| Enterprise Value | 184.28K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.28728 |
| Price/Book (mrq) | 0.0065573766 |
| Enterprise Value/Revenue | 0.369 |
| Enterprise Value/EBITDA | -0.272 |
Trading Information
MabCure Stock Price History
| Beta (5Y Monthly) | 0.02183 |
| 52-Week Change | -91.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0061 USD |
| 52 Week Low | 0.0002 USD |
| 50-Day Moving Average | 0.000228 USD |
| 200-Day Moving Average | 0.0012935 USD |
MBCI Share Statistics
| Avg. Volume (3 month) | 3.04K USD |
| Avg. Daily Volume (10-Days) | 46 USD |
| Shares Outstanding | 64.36M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 20:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2011 |
| Most Recent Quarter (mrq) | December 31, 2011 |
| Next Fiscal Year End | December 31, 2012 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -141.94% |
| Gross Margin | 100.00% |
| EBITDA Margin | -135.41% |
Management Effectiveness
| Return on Assets (ttm) | -4.22% |
| Return on Equity (ttm) | -125.14% |
Income Statement
| Revenue (ttm) | 500K USD |
| Revenue Per Share (ttm) | 0.008 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 500K USD |
| EBITDA | -677088 USD |
| Net Income Avi to Common (ttm) | -12264835 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 146.44K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 304.98K USD |
| Total Debt/Equity (mrq) | 7.87 USD |
| Current Ratio (mrq) | 0.17 |
| Book Value Per Share (mrq) | 0.061 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -61387 USD |
| Levered Free Cash Flow (ttm) | 114.53K USD |
Profile of MabCure
| Country | United States |
| State | NY |
| City | White Plains |
| Address | 21 Sparrow Circle |
| ZIP | 10605 |
| Phone | 845 591 3144 |
| Website | N/A |
| Industry | Solar |
| Sector(s) | Technology |
| Full Time Employees | 3 |
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Q&A For MabCure Stock
What is a current MBCI stock price?
MabCure MBCI stock price today per share is 0.0001 USD.
How to purchase MabCure stock?
You can buy MBCI shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MabCure?
The stock symbol or ticker of MabCure is MBCI.
Which industry does the MabCure company belong to?
The MabCure industry is Solar.
How many shares does MabCure have in circulation?
The max supply of MabCure shares is 70.3M.
What is MabCure Price to Earnings Ratio (PE Ratio)?
MabCure PE Ratio is now.
What was MabCure earnings per share over the trailing 12 months (TTM)?
MabCure EPS is -0.01 USD over the trailing 12 months.
Which sector does the MabCure company belong to?
The MabCure sector is Technology.